Journal Menu
► ▼ Journal Menu-
- JCM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
17 January 2023
Journal of Clinical Medicine | New Section “Clinical Pediatrics” Established
The Journal of Clinical Medicine (ISSN: 2077-0383) editorial team is pleased to announce the launch of a new Section, “Clinical Pediatrics”. The aim of this Section is to offer a platform for pediatric clinicians, physicians, and healthcare professionals to present cutting-edge basic and applied health research and quality clinical services in general and specialty pediatrics. We sincerely welcome your submission to the journal. Our readers are waiting for your contribution in original research on managing health and diagnosing and treating disorders in infants, children, and adolescents. Manuscripts can focus on research, practice, education, administration, or policy.
Topics could include but are not limited to the following:
- Neonatal medicine;
- Genetic and congenital conditions;
- Developmental–behavioral medicine;
- Pediatric surgery;
- Pediatric cardiology;
- Pediatric nephrology;
- Pediatric dermatology;
- Pediatric orthopedics;
- Pediatric stomatology;
- Pediatric infectious diseases;
- Pediatric pulmonary;
- Child and adolescent psychiatry;
- Pediatric neurology;
- Pediatric ophthalmology;
- Childhood cancer;
- Pediatric allergy and immunology;
- Pediatric endocrinology;
- Pediatric gastroenterology.
We are currently recruiting Editorial Board Members (EBMs) for this Section. If you are an active researcher in this field and are passionate about publishing cutting-edge research, please contact us at jcm@mdpi.com. Alternatively, you may wish to submit your work directly via the following link: https://susy.mdpi.com/user/manuscripts/upload/b407bd95154eb0a526717b8543b30b25?&journal=jcm.
JCM Editorial Office
22 December 2022
Special Issue Mentor Program
We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.
This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.
The mentee’s responsibilities include:
- Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
- Writing a brief promotion plan for the Special Issue;
- Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
- Writing an editorial for the online Special Issue together with the mentor.
The mentor’s responsibilities include:
- Conducting a final check before the Special Issue is published online;
- Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
- Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
- Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
- Making and submitting decisions regarding submissions with the assistance of mentees.
Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.
If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.
In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.
14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals
MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.
This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.
Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.
Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.
Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.
As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.
A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.
MDPI is proud to be the leading agent of the transition to open access.
"Thanks a Million" to all the contributors!
8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.
The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).
The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.
Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.
29 November 2022
Editorial Board Members from the Journal of Clinical Medicine Featured in the 2022 Highly Cited Researchers List Published by Clarivate
Recently, ClarivateTM revealed its 2022 list of Highly Cited ResearchersTM—individuals at universities, research institutes and commercial organizations.
The scientists who were selected into this year’s list of Highly Cited Researchers have published highly cited papers in the 11-year period from January 2011 to December 2021, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. Based on Web of Science Citation data, 6,938 researchers from across the globe who have demonstrated a disproportionate level of significant and broad influence in their chosen field or fields over the last decade have been awarded Highly Cited Researcher 2022 designations. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research sciences and social sciences.
According to statistics, eight members of the Editorial Board of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) have been selected into the list of Highly Cited Researchers of Clarivate in 2022. They are being recognized for their high-quality scientific research achievements and outstanding contributions to professional fields. The JCM journal office sincerely congratulates all elected Editorial Board Members and hopes that they continue to have an academically productive relationship with the journal.
|
Name |
Affiliation |
|
Prof. Dr. Aldo Pietro Maggioni |
Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Italy |
|
Prof. Dr. Laurent Peyrin-Biroulet |
Universite de Lorraine, France |
|
Dr. Holger Thiele |
University of Leipzig, Germany |
|
Dr. Peng Huang |
Shenzhen University, China Mainland |
|
Dr. Francesco Landi |
Catholic University of the Sacred Heart, Italy |
|
Dr. Francesc Graus |
University of Barcelona, Spain |
|
Prof. Dr. Hans-Peter Hartung |
Heinrich Heine University Dusseldorf, Germany |
|
Prof. Dr. Antonio Vita |
University of Brescia, Italy |
22 November 2022
Journal of Clinical Medicine | Special Issue Mentor Program
We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.
This program will enable early career researchers (required to hold a Ph.D. in a related field) to gain experience editing a Special Issue in MDPI journals under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to cultivate their ability to edit and process scientific research.
The mentee’s responsibilities include:
- Proposing a Special Issue title and, with the assistance of the mentor, preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
- Writing a brief promotion plan for the Special Issue;
- Preparing a list of scholars who may be interested in the Issue and personally e-mailing the invitations on behalf of Guest Editors;
- Writing an editorial for the online Special Issue together with the mentor.
The mentor’s responsibilities include:
- Conducting a final check before the Special Issue is published online;
- Performing editorial control of the Special issue and quality control of the publications in a timely manner;
- Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
- Organizing video calls with young scholars and the Editorial office regularly to discuss problems and improvement suggestions for the Special Issue.
- Making and submitting decisions for the submissions under the assistance of mentees.
Certificates and Awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.
If you are interested in this opportunity, please send your Special Issue proposal to the Journal of Clinical Medicine Editorial Office (jcm@mdpi.com), and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.
In addition to the new Special Issue Mentor Program, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) will continue to welcome all Special Issue proposals focusing on hot research topics.
4 November 2022
Meet Us at the 27th Congress of the Chinese Pediatric Society, 15–18 December 2022, Changsha, China
MDPI will be attending the 27th Congress of the Chinese Pediatric Society, held in Changsha, China, from 15–18 December 2022.

The following MDPI journals will be represented:
- Children (leading journal);
- JPM;
- Medicina;
- Audiology Research;
- JCM;
- Healthcare;
- Diagnostics;
- Metabolites;
- Cancers;
- Nutrients.
If you plan on attending this conference, feel free to stop by our booth: #B67. Our delegates look forward to meeting you in person to answer any questions that you may have.
For more information about the conference, please see the following link: https://nccps2022.tiemeeting.com/CN.
21 October 2022
Meet Us at the 15th European Public Health Conference 2022, 9–12 November 2022, Berlin, Germany
MDPI will be attending the 15th European Public Health Conference 2022, held in Berlin, Germany, from 9 to 12 November 2022. The theme of Berlin 2022 is “Strengthening Health Systems: Improving Population Health and Being Prepared for the Unexpected”. This conference will aim to explore ways in which the public health community can rally around the principle of bringing about better population health. Meanwhile, the conference committee wants the discussions at the 15th EPH Conference to contribute to resilient health systems, universal health coverage (UHC), a well-trained and highly qualified clinical and public health workforce, and governance structures that take a stand and shape health systems globally.
During this conference, MDPI (at booth #13) will welcome researchers from different backgrounds to visit and share their latest ideas with us.
The following MDPI journals will be represented:
- IJERPH;
- Medicina;
- JCM;
- EJIHPE;
- Epidemiologia;
- Behavioral Sciences;
- Healthcare;
- Women;
- MPs;
- Nursing Report;
- COVID;
- Diseases;
- Data;
- Adolescents.
If you plan on attending this conference, feel free to stop by our booth at #13. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please see the following link: https://ephconference.eu/index.php.
28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research
Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.
To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.
We invite you to view the event recording:
During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:
- Peer Review Week 2022
- Research Integrity
- What We’ve Learned About Peer Review Reports
- 4 Steps to the Perfect Peer Review Report
- How to Write the Perfect Peer Review Report: An Interview
- Inviting Great Peer Reviewers
In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.
You can find the Podcast here.
We hope you enjoy the contents!
21 September 2022
Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) Is Now an Affiliated Society Member of the Journal of Clinical Medicine
In September 2022, the Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) chose the Journal of Clinical Medicine (ISSN: ISSN 2077-0383) as its preferred journal and became an affiliated society member. As part of this collaboration, all members of GÉTICA will benefit from a discount on the article processing charge (APC) when submitting articles to the Journal of Clinical Medicine.
GÉTICA is a Spanish non-profit association that was established in 2014 by and for clinicians as well as scientists in basic and/or translational research who are interested in tumor immunology and immunotherapies for cancer treatment. The overarching aims of GÉTICA are as follows:
1) to advance the research on and development of novel immunotherapies;
2) to promote the education of researchers and clinicians in these fields;
3) to foster public engagement by communicating the latest developments in cancer immunology and immunotherapy.
A further priority is to integrate other scientific societies and cooperative groups with GÉTICA, in order to establish a strong multidisciplinary and collaborative scientific environment that will help us to drive the field of cancer immunology forward and further the development of novel immunotherapies.
The Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) is a professional organization whose functions are highly relevant to the scope of the Journal of Clinical Medicine.
We look forward to collaborating with GÉTICA and publishing state-of-the-art research from its members in this field.
